These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A; Glaumann H; Persson B; Broomé U Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [TBL] [Abstract][Full Text] [Related]
7. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Chascsa DM; Lindor KD Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911 [TBL] [Abstract][Full Text] [Related]
8. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? Harnois DM; Gores GJ; Ludwig J; Steers JL; LaRusso NF; Wiesner RH J Hepatol; 1997 Sep; 27(3):512-6. PubMed ID: 9314129 [TBL] [Abstract][Full Text] [Related]
9. Cancer surveillance in patients with primary sclerosing cholangitis. Razumilava N; Gores GJ; Lindor KD Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028 [TBL] [Abstract][Full Text] [Related]
10. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Demarchi B; Bresso F; Novero D; Palestro G; Sapone N; Pellicano R; Bonardi R; Smedile A; Rizzetto M; Astegiano M Minerva Gastroenterol Dietol; 2007 Sep; 53(3):279-83. PubMed ID: 17912190 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [TBL] [Abstract][Full Text] [Related]
14. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis. Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127 [TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. Leidenius M; Höckersted K; Broomé U; Ericzon BG; Friman S; Olausson M; Schrumpf E J Hepatol; 2001 Jun; 34(6):792-8. PubMed ID: 11451160 [TBL] [Abstract][Full Text] [Related]
17. Role of biliary brush cytology in primary sclerosing cholangitis. Lal A; Okonkwo A; Schindler S; De Frias D; Nayar R Acta Cytol; 2004; 48(1):9-12. PubMed ID: 14969174 [TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options. Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110 [TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis and malignancy. Boberg KM; Lind GE Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640 [TBL] [Abstract][Full Text] [Related]
20. Gallbladder polyps in primary sclerosing cholangitis: indication for early intervention. Schramm C; Lohse AW Hepatology; 2012 Jul; 56(1):396; author reply 396. PubMed ID: 22262471 [No Abstract] [Full Text] [Related] [Next] [New Search]